Efficacy and safety of ifupinostat (BEBT-908) in combination with rituximab for relapsed/refractory diffuse large B-cell lymphoma: Results from an exploratory phase Ib study.

diclostat (BEBT-908) - BeBetter Med

Rituxan (rituximab) - Roche

https://meetings.asco.org/abstracts-presentations/246055/

Peng Liu; Yufu Li; Yajun Li; Fang Zhu; Ying Cheng; Ou Bai; Wenyu Li; Hui Wu; Xinquan Liang; Yongdong Zhang; Hongwei Xue; Zhiming Li; Changgeng Qian; Yuankai Shi

Apr 23, 2025